Need Help?

Paired WES and low coverage WGS of osteosarcoma

Longitudinal genome-sequencing analysis of 12 patients with metastatic or refractory osteosarcoma. The study was approved at the University Hospital Basel, following the approval of the ethical committee for mutational analysis of anonymized samples (“Ethikkommission beider Basel” ref. 274/12). Informed consent was obtained from all 12 patients. All tumor samples were evaluated by an experienced bone pathologist to confirm the diagnosis. WES and low coverage WGS are aligned against the reference genome GRCh37. More details in the associated publication.

Request Access

The file access request must be send to Pr. Daniel Baumhoer from the University Hospital Basel : daniel.baumhoer@usb.ch

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom Bone Tumor Reference Centre grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: Bone Tumor Reference Centre and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify Bone Tumor Reference Centre within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify Bone Tumor Reference Centre prior to any significant changes to the protocol for the Project. 14. The User Institution will notify Bone Tumor Reference Centre as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. Bone Tumor Reference Centre may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than Bone Tumor Reference Centre. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts. Agreed for User Institution Signature: Name: Title: Date: Principal Investigator I confirm that I have read and understood this Agreement. Signature: Name: Title: Date: Agreed for Bone Tumor Reference Centre Signature: Name: Title: Date: APPENDIX I – DATASET DETAILS APPENDIX II ––PROJECT DETAILS APPENDIX III –– PUBLICATION POLICY APPENDIX I – DATASET DETAILS Dataset reference (EGA Study ID and Dataset Details) Name of project that created the dataset Early Evolutionary Landscape of Osteosarcoma Names of other data producers/collaborators Michal KOVAC Baptiste AMELINE Specific limitations on areas of research None Minimum protection measures required Cloud computing is prohibited. Data can be held in unencrypted files on an institutional compute system, with Unix user group read/write access for one or more appropriate groups but not Unix world read/write access behind a secure firewall. If held on Laptop, USB keys or other portable hard drives, the data must be encrypted. Only individuals that have obtained authorization will have access to the data. If copies of the data are stored locally on a shared computer system or a file server, then they must be strong password and/or encryption protected so that only the authorized individual have access to it. If the computer that holds the data is backed up, the backup media must encrypted and/or stored in a physically secure location. If the data are stored on a network-accessible computer, there must be controls in place to prevent access by computer “hackers”, or contamination by viruses, malware and spyware. Network security is usually implemented by your institution’s IT department and will consist of some combination of network firewalls, network intrusion monitoring and virus scanning software. After finishing the research project for which you are requesting access or if your access approval is terminated, you must securely destroy all local copies of the data, including any backups copies. However, if necessary, you may still keep the data for archival purpose in conformity with national audits or other legal requirements. APPENDIX II – PROJECT DETAILS (to be completed by the Requestor) Details of dataset requested i.e., EGA Study and Dataset Accession Number Brief abstract of the Project in which the Data will be used (500 words max) All Individuals who the User Institution to be named as registered users Name of Registered User Email Job Title Supervisor* All Individuals that should have an account created at the EGA Name of Registered User Email Job Title APPENDIX III – PUBLICATION POLICY Bone Tumor Reference Centre intends to publish the results of their analysis of this dataset and do not consider its deposition into public databases to be the equivalent of such publications. Bone Tumor Reference Centre anticipates that the dataset could be useful to other qualified researchers for a variety of purposes. However, some areas of work are subject to a publication moratorium. The publication moratorium covers any publications (including oral communications) that describe the use of the dataset. In any publications based on these data, please describe how the data can be accessed, including the name of the hosting database (e.g., The European Genome-phenome Archive at the European Bioinformatics Institute) and its accession numbers (e.g., EGAS00000000029), and acknowledge its use in a form agreed by the User Institution with Bone Tumor Reference Centre.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00005189446 1618225598934 5.0 GB
EGAF00005189448 1618219866881 6.7 GB
EGAF00005189449 1618220285185 12.7 GB
EGAF00005189450 1618220899229 6.5 GB
EGAF00005189451 1618220899229 6.5 GB
EGAF00005189452 1618220179849 8.5 GB
EGAF00005189453 bam 9.9 GB
EGAF00005189454 1618220106351 7.8 GB
EGAF00005189455 1618222578107 7.6 GB
EGAF00005189456 bam 9.9 GB
EGAF00005189457 1618222084350 5.0 GB
EGAF00005189458 1618225598934 8.5 GB
EGAF00005189459 1618224064173 7.9 GB
EGAF00005189460 1618228155043 20.0 GB
EGAF00005189461 1618221185373 15.6 GB
EGAF00005189462 bam 9.4 GB
EGAF00005189463 1618220825989 5.3 GB
EGAF00005189464 1618223165460 10.1 GB
EGAF00005189465 1618220765356 7.1 GB
EGAF00005189466 bam 9.8 GB
EGAF00005189467 bam 9.2 GB
EGAF00005189469 bam 9.4 GB
EGAF00005189470 bam 93.4 GB
EGAF00005189471 1618220825989 11.4 GB
EGAF00005189472 1618220720836 8.1 GB
EGAF00005189473 bam 6.4 GB
EGAF00005189474 1618219807131 6.5 GB
EGAF00005189475 1618223595867 5.5 GB
EGAF00005189476 bam 93.3 GB
EGAF00005189477 1618224676983 19.0 GB
EGAF00005189478 1618221018819 10.1 GB
EGAF00005189479 1618221559384 4.8 GB
EGAF00005189480 1618221018819 4.2 GB
EGAF00005189481 1618222463087 6.8 GB
EGAF00005189482 1618219204875 4.6 GB
EGAF00005189483 1618220059802 8.9 GB
EGAF00005189484 1618222988410 7.5 GB
EGAF00005189486 1618222805397 7.7 GB
EGAF00005189487 1618222865612 8.2 GB
EGAF00005189488 1618220477820 10.3 GB
EGAF00005189489 1618221244759 4.9 GB
EGAF00005189490 1618222578107 19.9 GB
EGAF00005189491 1618225598934 16.3 GB
EGAF00005189492 1618223295985 5.1 GB
EGAF00005189493 1618220001271 5.4 GB
EGAF00005189494 1618224378353 7.2 GB
EGAF00005189495 1618219699024 4.9 GB
EGAF00005189496 1618220239719 7.3 GB
EGAF00005189497 bam 9.9 GB
EGAF00005189498 1618223778915 10.5 GB
EGAF00005189499 1618221485311 3.9 GB
EGAF00005189500 1618224378353 4.6 GB
EGAF00005189501 1618224497677 5.0 GB
EGAF00005189502 1618226827685 18.8 GB
EGAF00005189503 1618220825989 7.6 GB
EGAF00005189504 1620404679683 22.1 GB
EGAF00005189505 bam 6.7 GB
EGAF00005189506 1618220285185 5.1 GB
EGAF00005189507 1618224858920 9.3 GB
EGAF00005189508 1618225945200 8.3 GB
EGAF00005189509 1618224004232 7.8 GB
EGAF00005189510 1618224197496 5.5 GB
EGAF00005189511 bam 9.2 GB
EGAF00005189512 1618221559384 6.3 GB
EGAF00005189513 1620404679684 19.0 GB
EGAF00005189514 1618225598934 23.1 GB
EGAF00005189515 1618223477571 5.7 GB
EGAF00005189516 1618221931607 6.0 GB
EGAF00005189517 1618223046791 5.2 GB
EGAF00005189518 1618227666686 18.3 GB
EGAF00005189519 1618220477820 5.2 GB
EGAF00005189520 1618224918347 6.3 GB
EGAF00005189521 1618218725257 8.8 MB
EGAF00005189522 1618218676337 8.7 MB
EGAF00005189523 1618218676337 8.8 MB
EGAF00005189524 1618218676337 7.1 MB
EGAF00005189525 1618218798950 8.5 MB
EGAF00005189526 1618218903699 7.0 MB
EGAF00005189527 1618218676337 7.0 MB
EGAF00005189528 1618218676337 7.1 MB
EGAF00005189529 1618218725257 6.8 MB
EGAF00005189530 1618218676337 8.8 MB
EGAF00005189531 1618218853106 6.7 MB
EGAF00005189532 1618218676337 8.8 MB
EGAF00005189533 1618218676337 8.9 MB
EGAF00005189534 1618218903699 7.0 MB
EGAF00005189535 1618218853106 6.9 MB
EGAF00005189536 1618218616725 8.2 MB
EGAF00005189538 1618218725257 8.7 MB
EGAF00005189539 1618218798950 8.8 MB
EGAF00005189540 1618218616726 8.8 MB
EGAF00005189541 1618218725257 8.8 MB
EGAF00005189542 1618218853106 8.8 MB
EGAF00005189543 1618218676337 8.8 MB
EGAF00005189544 1618218798950 8.8 MB
EGAF00005189545 1618218676338 7.8 MB
EGAF00005189546 1618218798950 7.9 MB
EGAF00005189547 1618218676338 8.9 MB
EGAF00005189548 1618218725257 8.8 MB
EGAF00005189549 1618218616725 8.7 MB
EGAF00005189550 1618218616727 8.8 MB
EGAF00005189551 1618218798950 8.7 MB
EGAF00005189552 1618218676338 6.9 MB
EGAF00005189553 1618218616727 6.9 MB
EGAF00005189554 1618218616727 8.0 MB
EGAF00005189555 1618218616725 6.9 MB
EGAF00005189556 1618218616725 6.9 MB
EGAF00005189557 1618218616725 6.9 MB
EGAF00005189558 1618218616725 8.7 MB
EGAF00005189559 1618218546654 7.7 MB
EGAF00005189560 1618218485134 7.6 MB
EGAF00005189561 1618218485134 6.8 MB
EGAF00005189562 1618218616725 7.1 MB
EGAF00005189564 1618218546654 7.9 MB
EGAF00005189565 1618218546654 8.8 MB
EGAF00005189566 1618218616726 6.9 MB
EGAF00005189567 1618218485134 7.7 MB
EGAF00005189568 1618218546654 7.0 MB
EGAF00005189569 1618218546654 7.0 MB
EGAF00005189570 1618218725257 6.8 MB
EGAF00005189571 1618218616728 8.8 MB
EGAF00005189572 1618218798950 7.7 MB
EGAF00005189573 1618218546654 8.8 MB
EGAF00005189574 1618218798950 8.8 MB
EGAF00005189575 1618218798950 8.7 MB
EGAF00005189576 1618218676338 6.8 MB
EGAF00005189577 1618218725257 8.8 MB
EGAF00005189579 1618218725257 8.8 MB
EGAF00005189580 1618218616725 8.3 MB
EGAF00005189581 1618218725257 8.3 MB
EGAF00005189582 1618218676337 8.4 MB
EGAF00005189583 1618218676337 7.4 MB
EGAF00005189584 1618218616725 8.8 MB
EGAF00005189585 1618218616728 7.5 MB
EGAF00005189586 1618218853106 8.0 MB
EGAF00005189587 1618218725257 8.1 MB
EGAF00005189588 1618218725257 8.7 MB
EGAF00005189589 1618218616728 8.1 MB
EGAF00005189590 1618218725257 7.4 MB
EGAF00005189591 1618218798950 7.0 MB
EGAF00005189592 1618218676338 8.8 MB
EGAF00005189593 1618218676338 8.8 MB
EGAF00005189594 1618218616728 7.0 MB
EGAF00005189595 1618218676338 8.8 MB
144 Files (816.2 GB)